|
Hokkaido University Collection of Scholarly and Academic Papers >
Faculty of Pharmaceutical Sciences >
Peer-reviewed Journal Articles, etc >
Therapeutic effects of soluble human leukocyte antigen G2 isoform in lupus-prone MRL/lpr mice
This item is licensed under:Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
| Title: | Therapeutic effects of soluble human leukocyte antigen G2 isoform in lupus-prone MRL/lpr mice |
| Authors: | Watanabe, Hiroshi Browse this author | | Kuroki, Kimiko Browse this author →KAKEN DB | | Yamada, Chisato Browse this author | | Saburi, Yukari Browse this author | | Maeda, Naoyoshi Browse this author →KAKEN DB | | Maenaka, Katsumi Browse this author →KAKEN DB |
| Keywords: | HLA-G2 | | LILRB2 | | PIR-B | | APCs | | SLE |
| Issue Date: | Apr-2020 |
| Publisher: | Elsevier |
| Journal Title: | Human immunology |
| Volume: | 81 |
| Issue: | 4 |
| Start Page: | 186 |
| End Page: | 190 |
| Publisher DOI: | 10.1016/j.humimm.2019.11.002 |
| Abstract: | Human leukocyte antigen (HLA)-G, a non-classical HLA class I molecule, has one of the splicing isoforms, HLA-G2, which lacks one domain (alpha 2) and forms a non-covalent homodimer. HLA-G2 is expressed on placental cells, regulatory T cells, tumor cells, and virus-infected cells, and is involved in immunosuppression. The major isoform of HLA-G, HLA-G1, binds to leukocyte immunoglobulin (Ig)-like receptor (LILR) B1 and LILRB2, on the contrary, HLA-G2 binds to only LILRB2. We previously reported that HLA-G2 bound LILRB2 more strongly than HLA-G1 and also to paired Ig-like receptor (PIR)-B, a mouse homolog of LILRBs. Furthermore, HLA-G2 showed immunosuppressive effects in both collagen-induced arthritis (CIA) and atopic dermatitis-like model mice. In this study, we examine in vivo effects of HLA-G2 in systemic lupus erythematosus (SLE) model mice. HLA-G2 showed the suppression of the typical SLE symptoms such as serum anti-dsDNA antibody level and urinary albumin index. Furthermore, HLA-G2 tended to downregulate B-lymphocyte stimulator (BLyS) production. This is the first observation of the immunosuppressive effects of HLA-G2 isoform in SLE model mice, suggesting that HLA-G2 could be a useful therapeutic agent for SLE. |
| Rights: | ©2020. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ | | https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| Type: | article (author version) |
| URI: | http://hdl.handle.net/2115/81221 |
| Appears in Collections: | 薬学研究院 (Faculty of Pharmaceutical Sciences) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|
Submitter: 黒木 喜美子
|
